| Cash Flow | 2025-09-30 | 2025-06-30 |
|---|---|---|
| Principal payments on finance leases | 42 | 29 |
| Net cash provided by (used in) financing activities | 9,768 | 58 |
| Net decrease in cash, cash equivalents and restricted cash | -65,581 | -77,773 |
| Cash and cash equivalents at beginning of period | 136,925 | - |
| Cash and cash equivalents at end of period | 71,344 | - |
Neurogene Inc. (NGNE)
Neurogene Inc. (NGNE)